Unosi

• Influence of risk factors for gonarthritis in different radiographic stages of disease (2003)

  N. Prodanović, B. Božić, A. Galić, L. Arsić, L. Rackov Petrović, I. Zgradić, Influence of risk factors for gonarthritis in different radiographic stages of disease, pp. 217 - 222, 2003

• Povezanost faktora rizika i fraktura kod žena sa osteoporozom (2004)

  N. Prodanović, B. Božić, I. Zgradić, Povezanost faktora rizika i fraktura kod žena sa osteoporozom, 2004

• C terminalni propeptid kolagena tip I i deoksipiridinolin u poređenju postmenopauzanle osteoporoze alendronatom i HCT (2004)

  N. Prodanović, B. Božić, I. Zgradić, C terminalni propeptid kolagena tip I i deoksipiridinolin u poređenju postmenopauzanle osteoporoze alendronatom i HCT, 2004

• Bone specific alkaline phosphatase and C terminal propeptide collagen type I in evaluating the successfulness of therapy by alendronate in treating osteoporotic women in Serbia (2004)

  N. Prodanović, B. Božić, I. Zgradić, Bone specific alkaline phosphatase and C terminal propeptide collagen type I in evaluating the successfulness of therapy by alendronate in treating osteoporotic women in Serbia, 2004

• The percentage of risk factors for women in Serbia with lower bone mineral density (2004)

  N. Prodanović, B. Božić, I. Zgradić, The percentage of risk factors for women in Serbia with lower bone mineral density, 2004

• Estimate the success of antiosteoporotic therapy by measuring of change of bone specific alkaline phosphatase values (2004)

  N. Prodanović, B. Božić, I. Zgradić, Estimate the success of antiosteoporotic therapy by measuring of change of bone specific alkaline phosphatase values, 2004

• Bone specific alkaline phosphatase and deoxypyridinoline in evaluating the successfulness of therapy by alendronate in treating osteoporotic women in Serbia (2004)

  N. Prodanović, B. Božić, I. Zgradić, Bone specific alkaline phosphatase and deoxypyridinoline in evaluating the successfulness of therapy by alendronate in treating osteoporotic women in Serbia, 2004

• Realtion between bone markers and fractures among non-treated women in Serbia suffering from postmenopausal osteoporosis. (2004)

  N. Prodanović, B. Božić, I. Zgradić, Realtion between bone markers and fractures among non-treated women in Serbia suffering from postmenopausal osteoporosis., 2004

• Treatment patients with rheumatoid arthritis with alternative dose of metotrexate (2004)

  N. Prodanović, B. Božić, I. Zgradić, Treatment patients with rheumatoid arthritis with alternative dose of metotrexate, 2004

• Glucosamine sulfate at gonarthritis treatment (2004)

  N. Prodanović, B. Božić, I. Zgradić, Glucosamine sulfate at gonarthritis treatment, 2004

• Uslovbljenost radiografskog stepena gonartroze faktorima rizika kod žena (2005)

  J. Vasić Vilkić, N. Prodanović, B. Božić, D. Jablanović, S. Radinović, O. Nikolić, Uslovbljenost radiografskog stepena gonartroze faktorima rizika kod žena, pp. 88 - 89, 2005

• Značaj lokalnih i soistemskih biohumoralnih parametara u reumatoidnom artritisu (2005)

  N. Prodanović, B. Božić, I. Zgradić, Značaj lokalnih i soistemskih biohumoralnih parametara u reumatoidnom artritisu, 2005

• Korelacija vrednosti heliksnih peptida sa mineralnom koštanom gustinom, skorom aktivnosti bolesti i stepenom radiografske progresije kod bolesnika sa reumatoidnim artritiusom (2005)

  N. Prodanović, B. Božić, I. Zgradić, Korelacija vrednosti heliksnih peptida sa mineralnom koštanom gustinom, skorom aktivnosti bolesti i stepenom radiografske progresije kod bolesnika sa reumatoidnim artritiusom, 2005

• Bone mineral density in chronic inflammatory disease (2005)

  N. Prodanović, B. Božić, I. Zgradić, Bone mineral density in chronic inflammatory disease, 2005

• Bone mineral density and frequence of risk factors in the industrial area in Serbia (2006)

  N. Prodanović, B. Božić, I. Zgradić, Bone mineral density and frequence of risk factors in the industrial area in Serbia, 2006

• Helical peptides in the evaluation of bone loss in patients with rheumatoid arthritis and osteoarthritis (2006)

  B. Božić, N. Prodanović, R. Petrović, Helical peptides in the evaluation of bone loss in patients with rheumatoid arthritis and osteoarthritis, 2006

• Assessment of risk factors for osteoporosis and bone mineral density in Serbia (2006)

  N. Prodanović, B. Božić, A. Dimić, Assessment of risk factors for osteoporosis and bone mineral density in Serbia, 2006

• Biohumoral parameters in patients with rheumatoid arthritis and osteoporosis (2006)

  N. Prodanović, B. Božić, I. Zgradić, Biohumoral parameters in patients with rheumatoid arthritis and osteoporosis, 2006

• Značaj antiosteoportičnih lekova u sprečavanju gubitka koštane mase kod pacijenata sa inflamatornim bolestima (2006)

  N. Prodanović, B. Božić, I. Zgradić, Značaj antiosteoportičnih lekova u sprečavanju gubitka koštane mase kod pacijenata sa inflamatornim bolestima, 2006

• Značaj anti-citrulinskih antitela i hrskavičnih oligomatriksnih proteina u diferencijalnoj dijagnozi artritisa različite etiologije (2007)

  B. Božić, N. Prodanović, R. Petrović, Značaj anti-citrulinskih antitela i hrskavičnih oligomatriksnih proteina u diferencijalnoj dijagnozi artritisa različite etiologije, 2007